[Antinuclear antibodies of undetermined significance and the risk of progression to immune-mediated inflammatory diseases: An update].

Levy L, Gérardin C, Mageau A, Sacre K

Open source

DOI
10.1016/j.revmed.2026.09.019
Published
2026 Oct 23
Container
La Revue de medecine interne
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.revmed.2026.09.019,
  title = {[Antinuclear antibodies of undetermined significance and the risk of progression to immune-mediated inflammatory diseases: An update].},
  author = {Levy L and Gérardin C and Mageau A and Sacre K},
  year = {2026},
  journal = {La Revue de medecine interne},
  doi = {10.1016/j.revmed.2026.09.019},
  url = {https://doi.org/10.1016/j.revmed.2026.09.019}
}

RIS

TY  - JOUR
TI  - [Antinuclear antibodies of undetermined significance and the risk of progression to immune-mediated inflammatory diseases: An update].
AU  - Levy L
AU  - Gérardin C
AU  - Mageau A
AU  - Sacre K
PY  - 2026
JO  - La Revue de medecine interne
DO  - 10.1016/j.revmed.2026.09.019
UR  - https://doi.org/10.1016/j.revmed.2026.09.019
ER  - 

APA

L, L., C, G., A, M., & K, S. (2026). [Antinuclear antibodies of undetermined significance and the risk of progression to immune-mediated inflammatory diseases: An update].. La Revue de medecine interne. https://doi.org/10.1016/j.revmed.2026.09.019

Source records